Skip to main content
Log in

Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia

  • Papers
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The clinical relevance of multidrug resistance gene (mdr1) expression in tumor cells remains largely unclear. Conflicting results regarding mdr1 gene expression and clinical outcome have been obtained. Little is known about regulation of mdr1 gene expression, and the conflicting results might be explained by the fact that mdr1 RNA levels do not reflect expression at the protein level. The aim of the present study was to investigate the relationship between mdr1 RNA levels and P-glycoprotein (Pgp) content of leukemic cells from patients with acute myelogenous or lymphocytic leukemia. Mdr1 RNA levels were determined by a quantitative RNA-RNA solution hybridization method, and Pgp by Western blot technique with enhanced chemiluminescence for immunodetection. Pgp was detected in 14/14 leukemic cell samples while mdr1 RNA was detectable (>0.15 copies/cell) in cells from only six out of the 14 patients. Mdr1 RNA levels did not correlate with the Pgp content of leukemic cells (r=0.284,p=0.306). Relapsed leukemias had significantly (p=0.016) higher levels of Pgp thande novo untreated leukemias (the mean and SD optical density units were 0.56±0.18 and 0.25±0.17 respectively) while no difference was found in RNA levels. The findings support post-transcriptional level regulation of mdr1 gene expression and stress the importance of accurate determinations of the Pgp content of tumor cells in studies of the relationship between mdr1 gene expression and clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McClean, S. and Hill, B.T. (1992) An overview of membrane, cytosolic and nuclear proteins associated with the expression of resistance to multiple drugsin vitro.Biochim. Biophys. Acta 1114, 107–27.

    PubMed  CAS  Google Scholar 

  2. Pastan, I. and Gottesman, M.M. (1991) Multidrug resistance.Ann. Rev. Med. 42, 277–86.

    Article  PubMed  CAS  Google Scholar 

  3. Juliano, R. and Ling, V. (1976) A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants.Biochim. Biophys. Acta 455, 152–62.

    Article  PubMed  CAS  Google Scholar 

  4. Willingham, M.C., Cornwell, M.M., Cardarelli, C.O., Gottesman, M.M. and Pastan, I. (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.Cancer Res. 46, 5941–46.

    PubMed  CAS  Google Scholar 

  5. Hamada, H. and Tsuruo, T. (1988) Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance: 170- to 180-kilodalton membrane glycoprotein is an ATPase.J. Biol. Chem. 263, 1454–8.

    PubMed  CAS  Google Scholar 

  6. Gros, P., Croop, J. and Housman, D. (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.Cell 47, 371–80.

    Article  PubMed  CAS  Google Scholar 

  7. Gsur, A., Zöchbauer, S., Götzl, M., Kyrle, P.A., Lechner, K. and Pirker, R. (1993) MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update.Leuk Lymphoma 12, 91–4.

    Article  PubMed  CAS  Google Scholar 

  8. Paietta, E., Andersen, J., Racevskis, J., Gallagher, R., Bennett, J., Yunis, J., Cassileth, P. and Wiernik, P.H. (1994) Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.Leukemia 8, 968–73.

    PubMed  CAS  Google Scholar 

  9. Nabors, M.W., Griffin, C.A., Zehnbauer, B.A., Hruban, R.H., Phillips, P.C., Grossman, S.A., Brem, H. and Colvin, O.M. (1991) Multidrug resistance gene (MDR1) expression in human brain tumors.J. Neurosurg. 75, 941–6.

    Article  PubMed  CAS  Google Scholar 

  10. Noonan, K.E., Beck, C., Holzmayer, T.A., Chin, J.E., Wunder, J.S., Andrulis, I.L., Gazdar, A.F., Willman, C.L., Griffith, B., Von Hoff, D. and Roninson, I.B. (1990) Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.Proc. Natl. Acad. Sci. USA 87, 7160–64.

    Article  PubMed  CAS  Google Scholar 

  11. Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M. and Pastan, I. (1987) Expression of a multidrug-resistance gene in human tumors and tissues.Proc. Natl. Acad. Sci. USA 84, 265–9.

    Article  PubMed  CAS  Google Scholar 

  12. Sato, H., Preisler, H., Day, R., Raza, A., Larson, R., Browman, G., Goldberg, J., Vogler, R., Grunwald, H., Gottlieb, A., Bennett, J., Gottesman, M. and Pastan, I. (1990) MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.Br. J. Haematol. 75, 340–5.

    Article  PubMed  CAS  Google Scholar 

  13. Marie, J.P., Zittoun, R. and Sikic, B.I. (1991) Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome andin vitro drug sensitivity.Blood 78, 586–92.

    PubMed  CAS  Google Scholar 

  14. Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O.A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., Ludwig, H. and Lechner, K. (1991) MDR1 gene expression and treatment outcome in acute myeloid leukemia.J. Natl. Cancer Inst. 83, 708–12.

    Article  PubMed  CAS  Google Scholar 

  15. Gruber, A., Vitols, S., Norgren, S., Areström, I., Peterson, C., Björkholm, M., Reizenstein, P. and Luthman, H. (1992) Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.Br. J. Cancer 66, 266–72.

    PubMed  CAS  Google Scholar 

  16. Zöchbauer, S., Gsur, A., Brunner, R., Kyrle, P.A., Lechner, K. and Pirker, R. (1994) P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia.Leukemia 8, 974–7.

    PubMed  Google Scholar 

  17. Lepelley, P., Soenen, V., Preudhomme, C., Lai, J.L., Cosson, A. and Fenaux, P. (1994) Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes.Leukemia 8, 998–1004.

    PubMed  CAS  Google Scholar 

  18. Cordon-Cardo, C., O’Brien, J.P., Boccia, J., Casals, D., Bertino, J.R. and Melamed, M.R. (1990) Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.J. Histochem. Cytochem. 38, 1277–87.

    PubMed  CAS  Google Scholar 

  19. Kuwazuru, Y., Yoshimura, A., Hanada, S., Utsunomiya, A., Makino, T., Ishibashi, K., Kodama, M., Iwahashi, M., Arima, T. and Akiyama, S. (1990) Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.Cancer 66, 868–73.

    Article  PubMed  CAS  Google Scholar 

  20. Campos, L., Guyotat, D., Jaffar, C., Solary, E., Archimbaud, E. and Treille, D. (1992) Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia.Eur. J. Haematol. 48, 254–8.

    Article  PubMed  CAS  Google Scholar 

  21. Wittebol, S., Te Boekhorst, P., Hagemeijer, A., Van Dongen, J.J.M., Schoester, M. and Sonneveld, P. (1992) Expression of the multidrug resistance (mdr-1) phenotype in acute myelocytic leukemia is associated with CD34 expression and monosomy 7 and predicts for poor survival.Blood 80, Suppl 1:202a.

  22. Zhou, D.C., Marie, J.P., Suberville, A.M. and Zittoun, R. (1992) Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods.Leukemia 6, 879–85.

    PubMed  CAS  Google Scholar 

  23. Willman, C.L., Kopecky, K.J., Weick, J., Appelbaum, F., Grever, M.R., Head, D.R., Elias, L., Balcerzak, S.P., Mills, G.M. and Hynes, H.E. (1992) Biologic parameters that predict treatment response inde novo acute myeloid leukemia (AML): CD34, but not multidrug resistance (MDR) gene expression, is associated with a decreased complete remission (CR) rate and CD34+ patients more frequently achieve CR with high dose cytosine arabinoside.Proc. ASCO 11, 262.

    Google Scholar 

  24. Sugawara, I., Koji, T., Ueda, K., Pastan, I., Gottesman, M.M., Nakane, P.K. and Mori, S. (1990)In situ localization of the human multidrug-resistance gene mRNA using thymine-thymine dimerized single-stranded cDNA.Jpn J. Cancer Res. 81, 949–55.

    PubMed  CAS  Google Scholar 

  25. Hegewisch-Becker, S., Fliegner, M., Tsuruo, T., Zander, A., Zeller, W. and Hossfeld, D.K. (1993) P-glycoprotein expression in normal and reactive bone marrows.Br. J. Cancer 67, 430–5.

    PubMed  CAS  Google Scholar 

  26. Kakehi, Y., Kanamaru, H., Yoshida, O., Ohkubo, H., Nakanishi, S., Gottesman, M.M. and Pastan, I. (1988) Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance.J. Urol. 139, 862–5.

    PubMed  CAS  Google Scholar 

  27. Mizoguchi, T., Yamada, K., Furukawa, T., Hidaka, K., Hisatsugu, T., Shimazu, H., Tsuruo, T., Sumizawa, T. and Akiyama, S. (1990) Expression of the MDR1 gene in human gastric and colorectal carcinomas.J. Natl. Cancer Inst. 82, 1679–83.

    Article  PubMed  CAS  Google Scholar 

  28. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D. and Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis.Blood 79, 473–6.

    PubMed  CAS  Google Scholar 

  29. Shen, D.W., Fojo, A., Chin, J.E., Roninson, I.B., Richert, N., Pastan, I. and Gottesman, M.M. (1986) Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.Proc. Natl. Acad. Sci. USA 83, 4538–42.

    Article  PubMed  Google Scholar 

  30. Scheper, R.J., Bulte, J.W.M., Brakkee, J.G.P., Quak, J.J., Van der Schoot, E., Balm, A.J.M., Meijer, C.J., Broxterman, H.J., Kuiper, C.M., Lankelma, J. and Pinedo, H.M. (1988) Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance.Int. J. Cancer 42, 389–94.

    Article  PubMed  CAS  Google Scholar 

  31. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. and Sultan, C. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.Br. J. Haematol. 33, 451–8.

    Article  PubMed  CAS  Google Scholar 

  32. Ueda, K., Clark, D.P., Chen, C.J., Roninson, I.B., Gottesman, M.M. and Pastan, I. (1987) The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation.J. Biol. Chem. 262, 505–8.

    PubMed  CAS  Google Scholar 

  33. Labarca, C. and Paigen, K. (1980) A simple, rapid, and sensitive DNA assay procedure.Anal Biochem. 102, 344–52.

    Article  PubMed  CAS  Google Scholar 

  34. Lowry, U.H., Rosenbrough, N.J., Farr, A.I. and Randall, R.L. (1951). Protein measurement with the Folin phenol reagent.J. Biol. Chem. 193, 265–75.

    PubMed  CAS  Google Scholar 

  35. Laemmili, U.K. (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4.Nature 227, 247–54.

    Google Scholar 

  36. Bates, S.E., Mickley, L.A., Chen, Y.N., Richert, N., Rudick, J., Biedler, J.L. and Fojo, A.T. (1989) Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.Mol. Cell. Biol. 9, 4337–44.

    PubMed  CAS  Google Scholar 

  37. Marino, P.A., Gottesman, M.M. and Pastan, I. (1990) Regulation of the multidrug resistance gene in regenerating rat liver.Cell Growth Differ. 1, 57–62.

    PubMed  CAS  Google Scholar 

  38. Chin, K.V., Tanaka, S., Darlington, G., Pastan, I. and Gottesman, M.M. (1990) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells.J. Biol. Chem. 265, 221–6.

    PubMed  CAS  Google Scholar 

  39. Hill, B.T., Deuchars, K., Hosking, L.K., Ling, V. and Whelan, R.D. (1990) Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiationin vitro.J. Natl. Cancer Inst. 82, 607–12.

    Article  PubMed  CAS  Google Scholar 

  40. McClean, S. and Hill, B.T. (1993) Post-translational regulation of P-glycoprotein in mammalian tumour cells expressing a distinctive multiple drug resistant phenotype after exposure to fractionated X — irradiation.Proc. AACR 34, 313.

    Google Scholar 

  41. Bradley, G., Naik, M. and Ling, V. (1989) P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines.Cancer Res. 49, 2790–6.

    PubMed  CAS  Google Scholar 

  42. Chen, Y.F., Murawski, M.J., Fredericks, W.J., Karakousis, C. and Baker R.M. (1990) Comparison of Western blot and RNA slot blot detection of mdr1 gene expression in human tumors.Proc. AACR 31, 537.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Albertioni, F., Gruber, A., Areström, I. et al. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia. Med Oncol 12, 79–86 (1995). https://doi.org/10.1007/BF01676707

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01676707

Keywords

Navigation